世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など...市場調査レポートについてご紹介

【英文タイトル】Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Key Take-Aways
1.2 Report Scope
1.3 Report Segmentation
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources
1.6 Logical Assumptions In This Study Based On Reliable Sources

2 Executive Summary (Page No. – 26)

3 Technology Snapshot (Page No. – 31)
3.1 Technology-Introduction
3.2 Technology-Evolution
3.3 Technology Segmentation
3.4 Technology Trends-By Class
3.4.1 Adjuvants
3.5 Key Vaccine Products In The Market
3.6 Technology Roadmap

4 Vaccine Research Portfolio (Page No. – 42)
4.1 Global Research Portfolio-Research And Development Network
4.2 Emerging Approaches To Vaccine Developments
4.3 Key Research Centres

5 Value Chain Analysis (Page No. – 47)
5.1 Overview
5.2 Cold Chain Management
5.3 Key Stakeholders
5.4 Gap Analysis
5.5 Porters Five Force Analysis

6 Market Landscape (Page No. – 57)
6.1 Global Vaccine Technologies Market, Global Forecasts (2013-2022)
6.1.1 Global Vaccine Technologies Market, By Geography, 2012-2022
6.1.2 Vaccine Technologies Market Segmentation
6.1.3 Market Dynamics
6.1.3.1 Drivers
6.1.3.2 Restraints
6.1.3.3 Opportunities, Threats And Challenges
6.2 Global Vaccine Technologies Market, By End-User, 2012-2022
6.2.1 Global Vaccine Technologies Market Share, By End-User, 2012-2022
6.2.2 Paedriatic Vaccine Market, By Geography
6.2.3 Global Paedriatic Vaccine Market Share, By Geography
6.2.4 Global Adult Vaccine Market, By Geography
6.2.5 Global Adult Vaccine Market Share, By Geography
6.3 Global Vaccine Technologies Market, By Type, 2012-2022
6.3.1 Global Vaccine Technologies Market Share, By Type, 2012-2022
6.3.2 Global Preventive Vaccine Market, By Geography, 2012-2022
6.3.3 Global Preventive Vaccine Market Share, By Geography, 2012-2022
6.3.4 Global Therapeutic Vaccine Market, By Geography, 2012-2022
6.3.5 Global Therapeutic Vaccine Market Share, By Geography, 2012-2022
6.4 Global Vaccine Technologies Market, By Class, 2012-2022
6.4.1 Global Vaccine Technologies Market Share, By Class, 2012-2022
6.4.2 Live/Attenuated Vaccine Market, By Geography
6.4.2.1 Live/ Attenuated Vaccine Market Share, By Geography
6.4.3 Toxoid Vaccine Market, By Geography
6.4.3.1 Toxoid Vaccine Market Share, By Geography
6.4.4 Conjugate Vaccine Market, By Geography
6.4.4.1 Conjugate Vaccine Market Share, By Geography
6.4.5 Sub-Unit Vaccine Market, By Geography
6.4.6 Recombinant Vector Vaccine Market, By Geography, 2012-2022
6.4.7 Dna Vaccine Market, By Geography, 2012-2022
6.4.8 Synthetic Vaccine Market, By Geography, 2012-2022
6.4.8.1 Synthetic Vaccine Market Share, By Geography, 2012-2022
6.4.9 Dentritic Vaccine Market, By Geography, 2012-2022
6.5 Vaccine Technology Market, By Disease Indication (2012 – 2022)
6.5.1 Infectious Disease Vaccine Market, By Geography
6.5.2 Cancer Vaccine Market, By Geography
6.5.3 Allergy Vaccine Market, By Geography
6.5.4 Others Vaccine Market, By Geography, 2012-2022
6.5.5 Others Potential Market, By Geography, 2016-2022

7 Technology Adoption (Page No. – 110)
7.1 Factors That Drive Adoption Of Vaccine Technologies (Demand And Supply Side Analysis)
7.2 North America-U.S. & Canada
7.3 Europe-U.K, Germany, France, Italy
7.4 Asia-China, India
7.5 RoW-Australia & Africa

8 Investment Analysis (Page No. – 122)
8.1 Investor Network
8.2 Investment Funding Analysis
8.3 Top Funding Organizations

9 Competitive Landscape (Page No. – 126)
9.1 Competitive Landscape Analysis-Overview
9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012-2013)
9.3 Vaccine Candidates In Pipeline-Allergy
9.4 Vaccine Candidates In Pipeline-Cancer
9.5 Vaccine Candidates In Pipeline-Infectious Diseases
9.6 Vaccine Candidates In Pipeline-Others

10 Regulatory Landscape (Page No. – 135)
10.1 Regulatory Landscape-Overview
10.2 Regulations-Geographic

11 Patent Analysis (Page No. – 140)
11.1 Patent Analysis-Overview
11.2 Patent Analysis By Company

12 Analyst Recommendations (Page No. – 143)
12.1 Introduction
12.2 Technology Management Strategies

13 Company Profiles (Page No. – 146)
13.1 Novartis AG
13.2 Glaxo Smithkline PLC
13.3 Merck & CO., INC.
13.4 Sanofi
13.5 Pfizer, INC.
13.6 Antigen Express, INC.
13.7 Aduro Biotech
13.8 Genticel
13.9 Biondvax Pharmaceuticals LTD
13.10 Immune Targeting Systems (ITS)
13.11 Prokarium
13.12 Immunobiology LTD
13.13 Liquidia Technologies
13.14 Alphavax
13.15 Bavarian Nordic

14 Appendix (Page No. – 177)
Inter-Country Comparison Of Mortality For Selected Cause Of Death


【レポート販売概要】

■ タイトル:世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など
■ 英文:Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022
■ 発行日:2013年8月
■ 調査会社:MarketsandMarkets
■ 商品コード:MD 2020
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。